CRISPR-Cas has been used by Kawamura et al., [55] to knock out the NANOG gene, as well as NANOGP8 (Nanog Homeobox Retrogene P8) in DU145 prostate cancer cells. Here, NANOGP8 is linked to Familial prostate cancer.